Ki Hyun Bae
Overview
Explore the profile of Ki Hyun Bae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bae K, Chan K, Kurisawa M
ACS Macro Lett
. 2022 Jun;
11(7):835-840.
PMID: 35713474
(-)-Epigallocatechin-3--gallate (EGCG), the most bioactive catechin in green tea, has drawn significant interest as a potent antioxidant and anti-inflammatory compound. However, the application of EGCG has been limited by its...
12.
Lee F, Bae K, Ng S, Yamashita A, Kurisawa M
RSC Adv
. 2022 Apr;
11(24):14285-14294.
PMID: 35423998
Fibroblast-like synoviocytes are a key effector cell type involved in the pathogenesis of rheumatoid arthritis. The major green tea catechin, epigallocatechin-3--gallate (EGCG), has attracted significant interest for rheumatoid arthritis therapy...
13.
Bae K, Wang L, Kurisawa M
J Mater Chem B
. 2020 Apr;
1(40):5371-5388.
PMID: 32261243
Over the past decades, injectable hydrogels have emerged as promising biomaterials because of their biocompatibility, excellent permeability, minimal invasion, and easy integration into surgical procedures. These systems provide an effective...
14.
Liang K, Bae K, Nambu A, Dutta B, Chung J, Osato M, et al.
Biomater Sci
. 2019 Nov;
8(1):497-505.
PMID: 31761907
Acute myeloid leukemia (AML) is an aggressive malignancy that leads to a poor prognosis even with intensive chemotherapy. As the key feature of AML is the blockade of hematopoietic cell...
15.
Yongvongsoontorn N, Chung J, Gao S, Bae K, Yamashita A, Tan M, et al.
ACS Nano
. 2019 Jul;
13(7):7591-7602.
PMID: 31262169
Although a few nanomedicines have been approved for clinical use in cancer treatment, that recognizes improved patient safety through targeted delivery, their improved efficacy over conventional drugs has remained marginal....
16.
Li L, Bae K, Ng S, Yamashita A, Kurisawa M
Acta Biomater
. 2018 Oct;
81:103-114.
PMID: 30273747
Enzymatic crosslinking chemistry using horseradish peroxidase (HRP) has been widely utilized as an effective approach to fabricating injectable hydrogels with high efficiency under mild reaction conditions. However, their clinical applications...
17.
Bae K, Tan S, Yamashita A, Ang W, Gao S, Wang S, et al.
Biomaterials
. 2017 Sep;
148:41-53.
PMID: 28961534
The green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG), has gained significant attention as a potent adjuvant to enhance the antitumor efficacy of cisplatin while mitigating its harmful side effects. Herein we report...
18.
Liu C, Bae K, Yamashita A, Chung J, Kurisawa M
Biomacromolecules
. 2017 Aug;
18(10):3143-3155.
PMID: 28806066
Hyaluronic acid (HA)-based biomaterials have demonstrated only limited in vivo stability as a result of rapid degradation by hyaluronidase and reactive oxidative species. The green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG), has...
19.
Bae K, Kurisawa M
Biomater Sci
. 2016 Jul;
4(8):1184-92.
PMID: 27374633
Hydrogels have evolved into indispensable biomaterials in the fields of drug delivery and regenerative medicine. This minireview aims to highlight the recent advances in the hydrogel design for controlled release...
20.
Liang K, Bae K, Lee F, Xu K, Chung J, Gao S, et al.
J Control Release
. 2016 Feb;
226:205-16.
PMID: 26855049
Nanosized polyelectrolyte complexes are attractive delivery vehicles for the transfer of therapeutic genes to diseased cells. Here we report the application of self-assembled ternary complexes constructed with plasmid DNA, branched...